Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / December / Guiding Principles for Industry Leadership
Precision medicine Companion diagnostics Voices in the Community Career Pathways Molecular Pathology

Guiding Principles for Industry Leadership

Sitting Down With… Rita Shaknovich, Chief Medical Officer at Agilent Technologies

By Helen Bristow 12/05/2025 Interview 4 min read

Share

Rita Shaknovich

What’s your remit as Chief Medical Officer in a global diagnostics company?

I would summarize my role as aligning Agilent’s corporate strategy with the needs of patients and the medical community. I contribute medical and clinical inputs at all stages of product development, with the guiding principle being safety and benefit for the patient and the labs. 

The only way to achieve that is to work cross-functionally with many groups in the company, as well as consulting external collaborators and end users. It’s a very collaborative role.

Did you always have leadership aspirations?

In my early career I was driven by my interests: science, molecular diagnostics, and translational medicine. I was lucky to secure roles that allowed me to grow and develop in the field, but I also had great mentors.

Whilst I didn’t aspire to particular career titles, with time and maturity I came to realize that titles give you the ability to influence. At this point in my career I appreciate having a position that allows me to influence strategy and outcomes. So, in that respect, leadership feels like a natural fit.

How would you describe your leadership style?

Strategic, visionary, and collaborative. I say visionary because I think it’s important for leaders to focus on the big picture, not just short-term deliverables, and to think aspirationally. 

But, at the same time, aspirations must be aligned with corporate priorities. And they need to be pragmatic, because we have to be able to execute on the vision. That’s where the strategic element comes in.

My other guiding principle is “Nothing can be achieved in isolation.” The way I work is always cross-functional and collaborative. 

How do you maintain self-development as a leader?

Keeping up to date with molecular diagnostic innovation is key. It’s a challenge, but I try to carve out dedicated reading time. I'm always amazed how much new information and inspiration one can extract from just 30 minutes focused reading from published literature.

Listening is also important. Attending conferences and other events allows me to interact with colleagues from both the academic research community and industry in person. I also connect with patient advocacy groups to stay abreast of their needs.

What advice would you give to women aspiring to leadership roles in science and technology?

I would advise women in science to acknowledge the interests and passions that motivate them. Success is more likely if it’s linked to internal drivers, so women should be true to themselves and pursue roles aligned with their scientific interests.

I have found it’s also important to have a degree of assertiveness if you want to progress and influence others. Don’t wait to be invited to the table, so to speak, but walk up, take a seat, and share your ideas.

The other thing that helped me progress has been having role models to inspire me. We are navigating increasingly complex career paths and transitions, and juggling multiple functions in work and family life – it’s inspiring to see other women doing that successfully.

Having great mentors from whom to seek advice is also crucial. I have noticed that women are seeking mentorship very proactively now. Early-career women seem to be more sophisticated in career navigation than I was at their stage. That gives me hope that there will be more women in industry leadership in the future.

What gets you out of bed in the morning?

I’m genuinely motivated by making tangible progress against my goals – by checking things off the to-do list. I also love working with my team at Agilent. They are brilliant people and I learn from them every day.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Helping Hand from AI in Prostate Cancer Diagnostics
Precision medicine
A Helping Hand from AI in Prostate Cancer Diagnostics

February 8, 2022

3 min read

Using AI to enhance personalized healthcare for patients with prostate cancer

The Ultimate Vision for Rare Disease
Precision medicine
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational pathology can take rare disease diagnostics to the next level

A Light in the Darkness
Precision medicine
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

In-House Matters
Precision medicine
In-House Matters

April 7, 2022

3 min read

Molecular pathology is complex – and the benefits of keeping it local are extensive

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.